TP53 and thymic carcinoma: Because all the pathogenic variants were found in patients with thymic carcinomas, we evaluated their disease-free survival (DFS) using the Kaplan–Mayer method and log-rank test according to the presence of any pathogenic variant or a pathogenic TP53 variant.